Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page
- Check5 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025, and the revision number has changed from v2.16.3 to v2.16.4.SummaryDifference1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to version 2.16.2, indicating a revision in the content. However, there are no significant changes to core content, names, pricing, or availability.SummaryDifference0.4%
- Check26 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check55 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe page has undergone significant content removal, including detailed information about a clinical study on risankizumab for psoriasis, while a new version number has been added.SummaryDifference12%
Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.